DSCM
RCEL icon

Divisadero Street Capital Management’s Avita Medical RCEL Stock Holding History

Divisadero Street Capital Management’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$370K Hold
100,000
– – 0.02% 105
2025
Q4 		$345K Hold
100,000
– – 0.02% 86
2025
Q3 		$511K Buy
+100,000
New +$522K 0.02% 142

Other funds holding RCEL

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Divisadero Street Capital Management's RCEL Position: Q1 2026 in Review

Divisadero Street Capital Management held its Avita Medical (RCEL) position steady in Q1 2026 at 100,000 shares worth $370K. The position accounts for 0.02% of the portfolio, ranked #105.

Divisadero Street Capital Management first reported a position in RCEL in Q3 2025 and has held it in 3 quarters since. The position peaked at $511K in Q3 2025. 79 funds tracked by Wall St. Rank hold RCEL as of Q1 2026.

  • Divisadero Street Capital Management held 100,000 shares of Avita Medical worth $370K as of Q1 2026.
  • Divisadero Street Capital Management left its Avita Medical share count unchanged in Q1 2026.
  • Avita Medical made up 0.02% of Divisadero Street Capital Management's portfolio in Q1 2026, its #105 holding.
  • Divisadero Street Capital Management first reported a position in Avita Medical in Q3 2025 and has held it in 3 quarters since.
  • Divisadero Street Capital Management's Avita Medical position peaked at $511K in Q3 2025.
  • 79 funds tracked by Wall St. Rank held Avita Medical as of Q1 2026.

Based on Divisadero Street Capital Management's 13F filing for Q1 2026, filed 15 May 2026.